Last updated on June 2018

Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis

Brief description of study

The purpose of the study is to determine the efficacy, dose response, and safety of evobrutinib in subjects with Rheumatoid Arthritis (RA), and to consider a dose to take forward into Phase III development.

Clinical Study Identifier: NCT03233230

Contact Investigators or Research Sites near you

Start Over

US Medical Information Information

GLOBE CLINICAL RESEARCH (Globe Badania Kliniczne Sp z o.o.)
Klodzko, Poland
  Connect »